Marshall S. Stanton - 13 Jun 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Signature
/s/ Marshall Stanton
Issuer symbol
AORT
Transactions as of
13 Jun 2025
Net transactions value
-$743,131
Form type
4
Filing time
16 Jun 2025, 20:22:21 UTC
Previous filing
12 May 2025
Next filing
18 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stanton Marshall S. SVP, Clinical & MD Affair 1655 ROBERTS BLVD., NW, KENNESAW /s/ Marshall Stanton 16 Jun 2025 0001849615

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Sale $248,953 -8,747 -8.3% $28.46 96,585 13 Jun 2025 Direct F1, F2
transaction AORT Common Stock Sale $35,669 -1,253 -1.3% $28.47 95,332 13 Jun 2025 Direct F1, F3
transaction AORT Common Stock Sale $406,601 -14,306 -15% $28.42 81,026 13 Jun 2025 Direct F1, F4
transaction AORT Common Stock Sale $51,909 -1,826 -2.3% $28.43 79,200 13 Jun 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
F2 Reflects weighted average price for Performance Stock Units. Range of prices were between $28.175 to $28.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects weighted average price for Employee Stock Purchase Plan. Range of prices were between $28.18 to $28.65. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Reflects weighted average price for Performance Stock Units. Range of prices were between $28.17 to $28.675. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.